In Phase C, individuals will get ABBV-744 and oral navitoclax. In Section D, individuals will obtain ABBV-744 and ruxolitinib. Individuals will receive treatment until eventually disease progression or the participants are unable to tolerate the study drugs. - Participant eaten grapefruit or grapefruit goods within 3 times previous to the https://abbv-744inacutemyeloidleu02457.59bloggers.com/32505925/how-much-you-need-to-expect-you-ll-pay-for-a-good-abbv-744-combination-therapy-with-chemotherapy